 Abstract, this study proposes a novel approach to deliver drugs to the eye-using engineered peptids that combine to melanin and reduce intraocular pressure. The results show that these peptids can be used to provide sustained therapeutic delivery in the eye and beyond. This article was authored by Henry T. Su, René T. Cho, Acha Rai, and others.